Stock AGN AEGON N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Aegon N.V. Euronext Amsterdam

Equities

AGN

NL0000303709

Market Closed - Euronext Amsterdam
Other stock markets
 09:05:28 26/04/2024 pm IST 		5-day change 1st Jan Change
5.82 EUR +1.61% Intraday chart for Aegon N.V. +5.40% +10.90%
10/04 Aegon: successful placement of bond issue CF
10/04 Aegon Prices $760 Million Note for General Corporate Purposes MT

Summary

  • Overall, the company has poor fundamentals for a medium to long-term investment strategy.
  • From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
  • The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.

Strengths

  • Its low valuation, with P/E ratio at 8.94 and 6.88 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
  • The company appears to be poorly valued given its net asset value.
  • The company is one of the best yield companies with high dividend expectations.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • Over the past twelve months, analysts' opinions have been strongly revised upwards.

Weaknesses

  • With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
  • The average consensus view of analysts covering the stock has deteriorated over the past four months.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Life & Health Insurance

1st Jan change Capi. Investor Rating ESG Refinitiv
AEGON N.V. Stock Aegon N.V.
+10.90% 10.89B
A
AXA Stock AXA
+14.78% 79.51B
B-
METLIFE, INC. Stock MetLife, Inc.
+6.49% 50.22B
B+
AFLAC INCORPORATED Stock Aflac Incorporated
+1.35% 48.11B
B
MANULIFE FINANCIAL CORPORATION Stock Manulife Financial Corporation
+9.53% 42.2B
B+
PRUDENTIAL FINANCIAL, INC. Stock Prudential Financial, Inc.
+6.55% 39.71B
B+
GENERALI Stock Generali
+19.34% 37.78B
B
SUN LIFE FINANCIAL INC. Stock Sun Life Financial Inc.
+2.84% 30.07B
B
GREAT-WEST LIFECO INC. Stock Great-West Lifeco Inc.
-7.77% 27.56B
B-
PRUDENTIAL PLC Stock Prudential plc
-18.42% 24.71B
A-
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
-
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. AGN Stock
  4. AGN Stock
  5. Ratings Aegon N.V.